Future of Pharmacy

Christopher Lis, senior director at JD Power, shared key insights about the report and what the pharmacy landscape currently looks like.

Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.

In pharmacy, this model encourages taking responsibility and the open reporting of errors and near-misses without fear of punishment.

The JD Power 2025 US Pharmacy Study reveals rising satisfaction with mail-order pharmacies and supermarkets, driving a shift in prescription fulfillment preferences.

The bill promises lower drug costs and greater innovation, but critics still have concerns.

Brad Cochran of Cardinal Health explains the One Voice Initiative, which aims to bolster independent pharmacies.

AI is transforming oncology by enhancing clinical trials, personalizing treatments, and improving pharmacy practices, promising faster, more precise cancer care.

Lawmakers across the country can learn from examples in states like Arkansas and Texas.

New executive orders and legislation aim to lower prescription drug costs and enhance access to pharmacist services for seniors across the US.

Yes. But that doesn’t tell the whole story.

We should begin to refer to these pharmacists in direct-to-career paths accordingly as “primary care pharmacists.”

A novel solution can strategically control the release of the drug in vivo.

Pharmacists lead the charge in implementing advanced therapeutics, navigating complex challenges and shaping the future of health care innovation.

Pharmacists navigate reimbursement challenges while advocating for legislative support and innovative models to enhance patient care and financial sustainability.

Counseling for behavior change helps patients understand the importance of their medications and make positive changes.

Advocacy fosters professional development, creates better working conditions, and enhances patient care.

Effectively communicating research findings to patients, health care professionals, and policy payers is necessary for engagement.

The executive order gives pharmaceutical companies 30 days to voluntarily lower prices.

Artificial intelligence (AI) can transform rare disease research by leveraging patient data, enhancing evidence generation, and improving communication between patients and health care professionals.

The Ensuring Community Access to Pharmacist Services (ECAPS) Act would enhance Medicare coverage for pharmacist services and ensure seniors can access essential care in underserved areas.

The coronary artery disease (CAD) predictive model help health care professionals tailor personalized treatment methods for patients.

AI transforms pharmacy practice by streamlining workflows and enhancing patient care, while pharmacists adapt to new roles and challenges in health care.

SOC emphasizes adaptability and individual professional judgment without compromising quality, as individuals are held to the standard and expertise of their practice area.

Alexandra Wolff, PharmD, BCOP, FHOPA, was awarded a fellow of HOPA at the 2025 annual meeting.

The future holds the promise of earlier diagnosis, more targeted therapies, and personalized neurological care, said speaker William D. Freeman, MD, FAAN.

Similar legislation could also address PBM practices in commercial insurance.

How PBMs Are Reshaping Access, Affordability, and Outcomes in Modern Health Care